Retrieved from Turan, S., et al
G., Sallese, M., Antonucci, I., Aleksandr Trofimov, Vladimir Khavinson, Trofimova, S., Bruno, A., & Ballerini, P
If no, because the injury is spread across multiple locations, because inflammation is the primary barrier rather than tissue damage at one spot, or because the patient is post-surgical and every affected area cannot be injected individually, TB-500 addresses the problem at the systemic level that BPC-157 cannot reach
Plasma Napa concentration should be measured at 4 hours or later after ingestion (earlier concentrations are unreliable)
Patients often experience steroid-like side effects (fluid retention, high blood sugar, mood changes, etc.)